Abstract:The tumor suppressor p53 plays a key role in the regulation of cell cycle, apoptosis, DNA repair, and senescence. It acts as a transcriptional factor, and is able to activate various genes to exert specific functions. MDM2, the main regulator of p53, inhibits the function of p53 through direct interaction. On the basis of this finding, inhibiting the MDM2-p53 interaction can be a potentially important target for cancer therapy. We showed here that L2, an analog of small-molecule MDM2 antagonist nutlins, stabilized p53 and selectively activated the p53 pathway in p53 wild-type A549 cells, resulting in a pronounced antiproliferation effect through inducing cell cycle arrest and apoptosis. Meanwhile, we confirmed by immunoprecipitation analysis that L2 could also inhibit MDM2-p53 interaction, similar to nutlin-1. Real-time PCR results revealed that L2 had no effect on the p53 gene transcriptional level, but it could induce the upregulation of p21 at the transcriptional level, which was the downstream of p53. Therefore, we concluded that the accumulation of p53 caused by L2 was mainly because of the decrease of the protein degradation rather than the elevation of p53 gene expression. Furthermore, no phosphor-p53 formed after L2 treatments, indicating that a genetoxic mechanism was unlikely to contribute to the activation of p53 by L2. In conclusion, the data acquired from A549 cells indicated that L2 exhibited high anti proliferation activity by disrupting MDM2-p53 interaction, and that the mechanism was derived from the activation of p53 and the p53 pathway. It was also surprising that L2 showed high anti proliferation effect against p53 null H L60 cells, which was quite different from nutlin-1. G(2)/M phase arrest might have contributed to the high anti proliferation activity of L2 on HL60 cells. The changes of p53 and MDM2 protein levels in L2-treated HL60 cells indicated that the mechanisms involved in the cell cycle arrest in A549 and HL60 cells were probably different, to which our future research would be devoted. Anti-Cancer Drugs 20:416-424 (C) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.

P53 INDEPENDENT G(0)/G(1) ARREST AND APOPTOSIS INDUCED BY A NOVEL RETINOID IN HUMAN BREAST-CANCER CELLS

Apoptosis Induction In Cancer Cells By A Novel Analogue Of 6-[3-(1-Adamantyl)-4-Hydroxyphenyl]-2-Naphthalenecarboxylic Acid Lacking Retinoid Receptor Transcriptional Activation Activity

P53 Independent G1 Arrest and Apoptosis Induced by Adriamycin.

Molecular Determinants of AHPN (Cd437)-Induced Growth Arrest and Apoptosis in Human Lung Cancer Cell Lines

Posttranscriptional Regulation Of P21(Waf1/Cip1) Expression In Human Breast Carcinoma Cells

Antagonist Analogue of 6-[3‘-(1-adamantyl)-4‘-hydroxyphenyl]-2-naphthalenecarboxylic Acid (AHPN) Family of Apoptosis Inducers That Effectively Blocks AHPN-Induced Apoptosis but Not Cell-Cycle Arrest

Effects of a Novel Retinoid on Cyclin D1and E in Breast Cancer Cells

N-(4-Hydroxyphenyl)retinamide is More Potent Than Other Phenylretinamides in Inhibiting the Growth of BRCA1-mutated Breast Cancer Cells.

N-(4-Hydroxyphenyl)Retinamide (4-Hpr)-mediated Biological Actions Involve Retinoid Receptor-Independent Pathways in Human Breast-Carcinoma

8-Acetonyldihydronitidine Inhibits the Proliferation of Human Colorectal Cancer Cells Via Activation of P53

Induction of P53 Expression and Apoptosis by a Recombinant Dual-Target MDM2/MDMX Inhibitory Protein in Wild-Type P53 Breast Cancer Cells.

P53-independent Downregulation of P73 in Human Cancer Cells Treated with Adriamycin

Efficient activation of p53 pathway in A549 cells exposed to L2, a novel compound targeting p53-MDM2 interaction.

The P53 Pathway is Synergized by P38 Mapk Signaling to Mediate 11,11 '-Dideoxyverticillin-induced G(2)/M Arrest

Cell Cycle-Independent Regulation Of P(21waf1/Cip1) And Retinoblastoma Protein During Okadaic Acid-Induced Apoptosis Is Coupled With Induction Of Bax Protein In Human Breast Carcinoma Cells

Effect of A Small-Molecule Mdm2/Mdmx Inhibitor on Cell Cycle Arrest and Apoptosis in Breast Cancer Cells.

Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.

Apoptotic Effect and Mechanisms of AHPN on Human Skin Malignant Melanoma Cell A375

Comparative transcriptomic analysis reveals adriamycin-induced apoptosis via p53 signaling pathway in retinal pigment epithelial cells

Induction Of Apoptosis Of Human B-Cll And All Cells By A Novel Retinoid And Its Nonretinoidal Analog

Inhibition of AKT/FoxO3a signaling induced PUMA expression in response to p53-independent cytotoxic effects of H1: A derivative of tetrandrine.